KR101302810B1 - 고형 의약 제제 - Google Patents
고형 의약 제제 Download PDFInfo
- Publication number
- KR101302810B1 KR101302810B1 KR1020067026736A KR20067026736A KR101302810B1 KR 101302810 B1 KR101302810 B1 KR 101302810B1 KR 1020067026736 A KR1020067026736 A KR 1020067026736A KR 20067026736 A KR20067026736 A KR 20067026736A KR 101302810 B1 KR101302810 B1 KR 101302810B1
- Authority
- KR
- South Korea
- Prior art keywords
- starch
- solid pharmaceutical
- formulation
- drug
- raw material
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
실시예 | 실시예 16 | 실시예 17 | 실시예 18 | 실시예 19 | 실시예 20 | 실시예 21 | 실시예 22 | 실시예 23 |
옥수수 전분(g) | 100 | 100 | 100 | 100 | 100 | 99 | 75 | 69 |
결정 셀룰로오스(g) | 100 | 80 | 80 | 80 | 80 | 51 | 51 | 51 |
첨가제(g) | - | 20 a) | 20 b) | 20 c) | 20 d) | - | 24 d) | 30 d) |
실로스타졸(g) | 100 | 100 | 100 | 100 | 100 | 150 | 150 | 150 |
AUCt (ng.hr/mL) |
AUC (ng.hr/mL) |
Cmax (ng/mL) |
|
실시예 3 | 761±274 (89%) |
824±286 (94%) |
172±72 (57%) |
실시예 3(Fed) | 784±131 (92%) |
1030±202 (116%) |
169±15 (56%) |
비교예 3 | 277±146 (33%) |
326±173 (37%) |
113±101 (37%) |
비교예 13 | 852±556 (100%) |
879±570 (100%) |
302±190 (100%) |
AUCt (ng.hr/mL) |
AUC∞ (ng.hr/mL) |
Cmax (ng/mL) |
|
실시예 23 | 861±192 (94%) |
968±279 (102%) |
212±24 (66%) |
비교예 23 | 322±211 (35%) |
471±351 (50%) |
106±71 (33%) |
비교예 13 | 916±663 (100%) |
947±678 (100%) |
322±227 (100%) |
Claims (16)
- (i) 실로스타졸과 통상의 원료 전분을 혼합하여 원료 조성물을 제조하는 단계, 및(ii) 상기 원료 조성물 중의 전분을 미리-젤라틴화하는 단계에 의해 제조되고, (a) 실로스타졸 및 (b) 제제의 총 중량을 기준으로 10 내지 90 중량%의 미리-젤라틴화된 전분을 포함하는, 서방성 제제인 고형 의약 제제.
- 제1항에 있어서, 상기 단계 (i)이 다른 통상적인 담체를 추가로 혼합하여 수행되는 것인 고형 의약 제제.
- 제1항 또는 제2항에 있어서, 상기 원료 전분이 옥수수 전분인 고형 의약 제제.
- 제1항 또는 제2항에 있어서, 과립 또는 산제인 고형 의약 제제.
- 제3항에 있어서, 과립 또는 산제인 고형 의약 제제.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- (i) 실로스타졸과 통상의 원료 전분을 혼합하여 원료 조성물을 제조하는 단계, 및(ii) 상기 원료 조성물 중의 전분을 미리-젤라틴화하는 단계를 포함하는, 서방성 제제인 고형 의약 제제의 제조 방법.
- 제15항에 있어서, 상기 단계 (i)이 다른 통상적인 담체를 추가로 혼합하여 수행되는 고형 의약 제제의 제조 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2004-00150557 | 2004-05-20 | ||
JP2004150557 | 2004-05-20 | ||
PCT/JP2005/009583 WO2005113009A1 (en) | 2004-05-20 | 2005-05-19 | Solid pharmaceutical formulation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020127006492A Division KR20120030606A (ko) | 2004-05-20 | 2005-05-19 | 고형 의약 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070034002A KR20070034002A (ko) | 2007-03-27 |
KR101302810B1 true KR101302810B1 (ko) | 2013-09-02 |
Family
ID=35428258
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067026736A KR101302810B1 (ko) | 2004-05-20 | 2005-05-19 | 고형 의약 제제 |
KR1020127006492A KR20120030606A (ko) | 2004-05-20 | 2005-05-19 | 고형 의약 제제 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020127006492A KR20120030606A (ko) | 2004-05-20 | 2005-05-19 | 고형 의약 제제 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8821936B2 (ko) |
EP (1) | EP1755682A4 (ko) |
KR (2) | KR101302810B1 (ko) |
CN (1) | CN1984682B (ko) |
AR (1) | AR048970A1 (ko) |
AU (1) | AU2005244707B2 (ko) |
BR (1) | BRPI0511298A (ko) |
CA (1) | CA2567400C (ko) |
HK (1) | HK1105358A1 (ko) |
MX (1) | MXPA06013407A (ko) |
MY (1) | MY153696A (ko) |
RU (1) | RU2390332C2 (ko) |
SG (1) | SG152285A1 (ko) |
TW (1) | TWI338583B (ko) |
WO (1) | WO2005113009A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080085309A1 (en) * | 2006-09-14 | 2008-04-10 | Astellas Pharma Inc. | Rapidly disintegrating tablets in buccal cavity and manufacturing method thereof |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
AR071706A1 (es) * | 2008-05-15 | 2010-07-07 | Otsuka Pharma Co Ltd | Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion. |
EP3409294A1 (en) | 2017-06-01 | 2018-12-05 | Przedsiebiorstwo Farmaceutyczne Lek-Am Sp Z O. O. | Tablets containing cilostazol of specific particle size distribution |
RU2686066C1 (ru) * | 2018-05-11 | 2019-04-24 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Лекарственная форма цилостазола замедленного высвобождения |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000054752A1 (fr) * | 1999-03-15 | 2000-09-21 | Kaken Pharmaceutical Co., Ltd. | Comprimes a delitement rapide et procede de fabrication |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB825892A (en) | 1957-05-24 | 1959-12-23 | Ici Ltd | Tabletting process |
US4266348A (en) * | 1978-12-15 | 1981-05-12 | Cpc International Inc. | Fluidized bed process |
GB8624213D0 (en) | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
US4755397A (en) | 1986-12-24 | 1988-07-05 | National Starch And Chemical Corporation | Starch based particulate encapsulation process |
FR2610827B1 (fr) | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
FR2618073B1 (fr) | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
US5073380A (en) | 1987-07-27 | 1991-12-17 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
FR2666506A1 (fr) | 1990-09-07 | 1992-03-13 | Pf Medicament | Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation. |
CN1168102A (zh) | 1995-01-10 | 1997-12-17 | 大制药株式会社 | 树脂微粒及含该树脂微粒的药用材料和药剂 |
JP4022269B2 (ja) | 1995-05-26 | 2007-12-12 | 協和醗酵工業株式会社 | 医薬組成物 |
WO1997004752A1 (en) | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
CZ298690B6 (cs) * | 1995-12-27 | 2007-12-27 | Tibotec Pharmaceuticals Ltd. | Bioadhezivní farmaceutická kompozice, dávková forma a suchý zpusob prípravy tablet |
DK0922464T3 (da) * | 1996-07-12 | 2005-06-06 | Daiichi Seiyaku Co | Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme |
AU744156B2 (en) | 1996-10-28 | 2002-02-14 | General Mills Inc. | Embedding and encapsulation of controlled release particles |
JPH10182701A (ja) | 1996-12-26 | 1998-07-07 | Sanei Toka Kk | 溶出性向上粉末及びその製造方法 |
US6129932A (en) * | 1997-09-05 | 2000-10-10 | Merck & Co., Inc. | Compositions for inhibiting platelet aggregation |
JPH11286456A (ja) | 1998-03-31 | 1999-10-19 | Lion Corp | 複合粉体組成物及び錠剤 |
JP2002537231A (ja) | 1998-05-01 | 2002-11-05 | カトラー,ニール,アール | 特定の患者群における性的機能障害の治療 |
JP4748839B2 (ja) | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
EG23951A (en) * | 1999-03-25 | 2008-01-29 | Otsuka Pharma Co Ltd | Cilostazol preparation |
US6667060B1 (en) | 1999-03-31 | 2003-12-23 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
JP4641696B2 (ja) | 1999-09-30 | 2011-03-02 | 大塚製薬株式会社 | 消化管下部溶解性コーティング製剤 |
WO2001070697A1 (en) | 2000-03-20 | 2001-09-27 | Teva Pharmaceutical Industries Ltd. | Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide |
US6515128B2 (en) | 2000-03-20 | 2003-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
JP4637338B2 (ja) * | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
JP2002193792A (ja) * | 2000-12-25 | 2002-07-10 | Lion Corp | フィルムコーティング錠剤及びエロージョン防止組成物 |
JP2003063965A (ja) | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
US6509040B1 (en) * | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
US6531603B1 (en) | 2001-06-29 | 2003-03-11 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6596871B2 (en) | 2001-06-29 | 2003-07-22 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6388080B1 (en) | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
CN1210026C (zh) * | 2002-10-09 | 2005-07-13 | 重庆太极医药研究院 | 褪黑素双层控释片及制备工艺 |
AU2003301762B2 (en) | 2002-10-25 | 2006-02-09 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
US20050255155A1 (en) * | 2004-05-11 | 2005-11-17 | Glenmark Pharmaceuticals Limited | Modified release cilostazol compositions |
-
2005
- 2005-05-04 TW TW094114355A patent/TWI338583B/zh not_active IP Right Cessation
- 2005-05-09 MY MYPI20052068A patent/MY153696A/en unknown
- 2005-05-19 BR BRPI0511298-2A patent/BRPI0511298A/pt not_active IP Right Cessation
- 2005-05-19 KR KR1020067026736A patent/KR101302810B1/ko active IP Right Grant
- 2005-05-19 CA CA2567400A patent/CA2567400C/en not_active Expired - Fee Related
- 2005-05-19 AU AU2005244707A patent/AU2005244707B2/en not_active Ceased
- 2005-05-19 KR KR1020127006492A patent/KR20120030606A/ko not_active Application Discontinuation
- 2005-05-19 RU RU2006145311/15A patent/RU2390332C2/ru not_active IP Right Cessation
- 2005-05-19 EP EP05743223A patent/EP1755682A4/en not_active Withdrawn
- 2005-05-19 WO PCT/JP2005/009583 patent/WO2005113009A1/en active Application Filing
- 2005-05-19 MX MXPA06013407A patent/MXPA06013407A/es active IP Right Grant
- 2005-05-19 US US11/596,219 patent/US8821936B2/en not_active Expired - Fee Related
- 2005-05-19 SG SG200902964-6A patent/SG152285A1/en unknown
- 2005-05-19 CN CN2005800239543A patent/CN1984682B/zh not_active Expired - Fee Related
- 2005-05-19 AR ARP050102057A patent/AR048970A1/es unknown
-
2007
- 2007-10-03 HK HK07110687.0A patent/HK1105358A1/xx not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000054752A1 (fr) * | 1999-03-15 | 2000-09-21 | Kaken Pharmaceutical Co., Ltd. | Comprimes a delitement rapide et procede de fabrication |
Also Published As
Publication number | Publication date |
---|---|
HK1105358A1 (en) | 2008-02-15 |
CA2567400C (en) | 2012-09-25 |
KR20120030606A (ko) | 2012-03-28 |
BRPI0511298A (pt) | 2007-12-04 |
TW200538161A (en) | 2005-12-01 |
AU2005244707B2 (en) | 2011-08-11 |
MY153696A (en) | 2015-03-13 |
KR20070034002A (ko) | 2007-03-27 |
AU2005244707A1 (en) | 2005-12-01 |
MXPA06013407A (es) | 2007-01-23 |
WO2005113009A1 (en) | 2005-12-01 |
SG152285A1 (en) | 2009-05-29 |
TWI338583B (en) | 2011-03-11 |
US8821936B2 (en) | 2014-09-02 |
EP1755682A4 (en) | 2012-11-07 |
RU2006145311A (ru) | 2008-07-10 |
US20080033009A1 (en) | 2008-02-07 |
CN1984682A (zh) | 2007-06-20 |
RU2390332C2 (ru) | 2010-05-27 |
AR048970A1 (es) | 2006-06-14 |
EP1755682A1 (en) | 2007-02-28 |
CA2567400A1 (en) | 2005-12-01 |
CN1984682B (zh) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI433679B (zh) | 藥學固體製劑 | |
KR101302810B1 (ko) | 고형 의약 제제 | |
KR101585280B1 (ko) | 고형 의약 제제 | |
JP5112619B2 (ja) | 固形医薬製剤 | |
WO2008015686A1 (en) | Stable multiparticulate formulations of didanosine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20120214 Effective date: 20130612 |
|
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160624 Year of fee payment: 4 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016100003181; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161012 Effective date: 20170131 |
|
FPAY | Annual fee payment |
Payment date: 20170804 Year of fee payment: 5 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
FPAY | Annual fee payment |
Payment date: 20180730 Year of fee payment: 6 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018100000352; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180205 Effective date: 20181211 |
|
J206 | Request for trial to confirm the scope of a patent right | ||
J206 | Request for trial to confirm the scope of a patent right | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018100004159; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20181214 Effective date: 20190410 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2019100001115; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190408 Effective date: 20190528 |
|
FPAY | Annual fee payment |
Payment date: 20190729 Year of fee payment: 7 |